Home
Lupin Limited
Press Release Jan 09 2023
Business
Jan 9 2023
4 min read

Press Release Jan 09 2023

Lupin Limited has informed the Exchange regarding a press release dated January 09, 2023, titled "Lupin and Exeltis Announce Reimbursement Approval of NaMuscla�� in Spain for theSymptomatic Treatment of Myotonia in Adults with non-dystrophic myotonic (NDM)Disorders.".

View Attachment

Original text
Rate this translation
Your feedback will be used to help improve Google Translate